<DOC>
	<DOCNO>NCT02556619</DOCNO>
	<brief_summary>The purpose research study evaluate effect early palliative care consultation quality life , use hospital resource , end-of-life care survival among Hepatocellular Carcinoma ( HCC ) patient advanced End Stage Live Disease eligible potentially curative local area therapy . Half patient receive early palliative care diagnosis HCC half receive palliative care standard therapy treatment exhaust .</brief_summary>
	<brief_title>Randomized Control Trial ( RCT ) Early Palliative Care HCC</brief_title>
	<detailed_description>Intro : Hypothesis Methods Analysis Anticipated Results Palliative care focus provide relief symptom stress associate cancer . This help improve quality life cancer patient family . This care usually offer patient standard therapy treatment exhaust .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Diagnosed HCC biopsy liver protocol CT scan MRI characteristic Permanent street address Harris County , Texas consent study participation English Spanish speak ability respond QoL questionnaires ChildPugh C , eligible liver transplantation ( TXP ) , surgical resection , ablation , locoregional systemic therapy ChildPugh C , eligible systemic chemotherapy ( Sorafenib ) , eligible TXP , surgical resection , ablation locoregional therapy ChildPugh A B , eligible surgical resection ablation ( &gt; 3 lesion 2 lesion one &gt; 5cm ) ChildPugh A , eligible TXP , surgical resection , ablation locoregional therapy Primary modality treatment potentially curative TXP , surgical resection ablation deem GI MDC ChildPugh A B ( 2 lesion &lt; 5cm size ) Medical ( e.g . severe encephalopathy ) , psychological social condition may interfere patient 's participation study evaluation study result Any medical condition ( acute myocardial infarction stroke ) could jeopardize safety patient his/her compliance study Vulnerable population ( inmate jail prison ) NonEnglish NonSpanish Speaking patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Liver Cancer</keyword>
	<keyword>Randomized Control Trial</keyword>
	<keyword>Palliative Care</keyword>
	<keyword>Liver Cell Carcinoma</keyword>
	<keyword>Palliative Therapy</keyword>
</DOC>